89 related articles for article (PubMed ID: 21742756)
1. The effect of a cardiopulmonary bypass system with biocompatible coating on fibrinogen levels determined by the TEG--functional fibrinogen method: preliminary results.
Fluger I; Maderová K; Simek M; Hájek R; Zapletalová J; Lonsky V
Perfusion; 2011 Nov; 26(6):503-9. PubMed ID: 21742756
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
3. Are any biocompatible coatings capable of attenuating the deleterious effects of cardiopulmonary bypass?
Marcoux JE; Mycyk TR
Perfusion; 2013 Sep; 28(5):433-9. PubMed ID: 23630197
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
5. Active or passive bio-coating: does it matters in extracorporeal circulation?
Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G
Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
[TBL] [Abstract][Full Text] [Related]
6. [The evaluation of the bio-compatibility and the clinical usefulness of heparin-coated cardiopulmonary bypass circuits].
Yamanaka J; Takeuchi Y; Torii S; Gomi A; Nakatani H; Kohno K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Jan; 44(1):47-53. PubMed ID: 8683171
[TBL] [Abstract][Full Text] [Related]
7. The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children.
Moganasundram S; Hunt BJ; Sykes K; Holton F; Parmar K; Durward A; Murdoch IA; Austin C; Anderson D; Tibby SM
Anesth Analg; 2010 Apr; 110(4):995-1002. PubMed ID: 20142345
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
[TBL] [Abstract][Full Text] [Related]
9. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
10. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
[TBL] [Abstract][Full Text] [Related]
11. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
[TBL] [Abstract][Full Text] [Related]
13. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
[TBL] [Abstract][Full Text] [Related]
14. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.
Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H
Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821
[TBL] [Abstract][Full Text] [Related]
15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
16. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
Bagge L; Borowiec JW; Thelin S; Hultman J
Scand Cardiovasc J; 1997; 31(5):275-81. PubMed ID: 9406294
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
[TBL] [Abstract][Full Text] [Related]
18. Response of the cellular immune system to cardiopulmonary bypass is independent of the applied pump type and of the use of heparin-coated surfaces.
Misoph M; Schwender S; Babin-Ebell J
Thorac Cardiovasc Surg; 1998 Aug; 46(4):222-7. PubMed ID: 9776497
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model.
Suhara H; Sawa Y; Nishimura M; Oshiyama H; Yokoyama K; Saito N; Matsuda H
Ann Thorac Surg; 2001 May; 71(5):1603-8. PubMed ID: 11383807
[TBL] [Abstract][Full Text] [Related]
20. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
